Orchestra BioMed Holdings, Inc. OBIO
6.58 USD -0.42 (-6.00%)
Regular-session close
6.58 0.00 0.00%
After hours · Nov 20, 4:01 PM ET
6.47 Day range 7.14
3.49 52-week range 7.46
- YTD
- +58.55%
- 1 year
- +48.53%
News
benzinga.com B. Riley Securities Reiterates Buy on Orchestra BioMed Hldgs, Raises Price Target to $12 B. Riley Securities analyst Madison El-Saadi reiterates Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy and raises the price target from $11 to $12.
globenewswire.com Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference NEW HOPE, Pa., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact…
zacks.com Wall Street Analysts Think Orchestra BioMed Holdings, Inc. (OBIO) Could Surge 72.41%: Read This Before Placing a Bet The mean of analysts' price targets for Orchestra BioMed Holdings, Inc. (OBIO) points to a 72.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong…benzinga.com HC Wainwright & Co. Maintains Buy on Orchestra BioMed Hldgs, Raises Price Target to $12 HC Wainwright & Co. analyst Yi Chen maintains Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy and raises the price target from $10 to $12.
benzinga.com BTIG Maintains Buy on Orchestra BioMed Hldgs, Raises Price Target to $12 BTIG analyst Marie Thibault maintains Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy and raises the price target from $10 to $12.
benzinga.com Orchestra BioMed Hldgs Q3 EPS $(0.30) Beats $(0.40) Estimate, Sales $91.000K Miss $106.000K Estimate Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.40) by 25 percent. This is a 25 percent increase over losses of…
benzinga.com Orchestra BioMed Commences Common Stock Offering; Terms Not Disclosed Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) ("Orchestra BioMed" or the "Company"), a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers TransMedics Group (NASDAQ:TMDX) stock rose 17.6% to $81.16 during Thursday's after-market session. The company's market cap stands at $2.5 billion. The company's, Q3 earnings came out today.
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Pomdoctor (NASDAQ:POM) shares rose 25.6% to $1.47 during Friday's after-market session. The market value of their outstanding shares is at $8.3 million. GeneDx Holdings (NASDAQ:WGS) shares…
